Tags

Type your tag names separated by a space and hit enter

Thiomersal-containing vaccines - a review of the current state of knowledge.
Przegl Epidemiol 2015; 69(1):59-64, 157-61PE

Abstract

Thiomersal is an organomercury compound known for its antiseptic and antifungal properties and used as an antibacterial agent in pharmaceutical products, including vaccines and other injectable biological products. In recent years, concerns about the possible link between immunization with thiomersal-containing vaccines and autism development have grown. Many case-control and cohort studies have been conducted on a number of populations, and none of them have confirmed the hypothetical relation between thiomersal and increased risk of autism spectrum disorders (ASDs) development. It is also confirmed by the fact, that since 1999, number of thiomersal-containing vaccines used worldwide is decreasing year by year, while the prevalence of ASDs cases is rising. There are no contraindications to the use of vaccines with thiomersal in infants, children and non-pregnant women. The risk of serious complications associated with the development of diseases in unvaccinated individuals far outweighs the potential risk of adverse consequences associated with immunization with thiomersal-containing vaccines.

Authors+Show Affiliations

Department of Sera and Vaccines Evaluation, National Institute of Public Health - National Institute of Hygiene in Warsaw.Department of Sera and Vaccines Evaluation, National Institute of Public Health - National Institute of Hygiene in Warsaw.

Pub Type(s)

Journal Article
Review

Language

eng pol

PubMed ID

25862449

Citation

Gołoś, Aleksandra, and Anna Lutyńska. "Thiomersal-containing Vaccines - a Review of the Current State of Knowledge." Przeglad Epidemiologiczny, vol. 69, no. 1, 2015, pp. 59-64, 157-61.
Gołoś A, Lutyńska A. Thiomersal-containing vaccines - a review of the current state of knowledge. Przegl Epidemiol. 2015;69(1):59-64, 157-61.
Gołoś, A., & Lutyńska, A. (2015). Thiomersal-containing vaccines - a review of the current state of knowledge. Przeglad Epidemiologiczny, 69(1), pp. 59-64, 157-61.
Gołoś A, Lutyńska A. Thiomersal-containing Vaccines - a Review of the Current State of Knowledge. Przegl Epidemiol. 2015;69(1):59-64, 157-61. PubMed PMID: 25862449.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Thiomersal-containing vaccines - a review of the current state of knowledge. AU - Gołoś,Aleksandra, AU - Lutyńska,Anna, PY - 2015/4/12/entrez PY - 2015/4/12/pubmed PY - 2015/7/3/medline SP - 59-64, 157-61 JF - Przeglad epidemiologiczny JO - Przegl Epidemiol VL - 69 IS - 1 N2 - Thiomersal is an organomercury compound known for its antiseptic and antifungal properties and used as an antibacterial agent in pharmaceutical products, including vaccines and other injectable biological products. In recent years, concerns about the possible link between immunization with thiomersal-containing vaccines and autism development have grown. Many case-control and cohort studies have been conducted on a number of populations, and none of them have confirmed the hypothetical relation between thiomersal and increased risk of autism spectrum disorders (ASDs) development. It is also confirmed by the fact, that since 1999, number of thiomersal-containing vaccines used worldwide is decreasing year by year, while the prevalence of ASDs cases is rising. There are no contraindications to the use of vaccines with thiomersal in infants, children and non-pregnant women. The risk of serious complications associated with the development of diseases in unvaccinated individuals far outweighs the potential risk of adverse consequences associated with immunization with thiomersal-containing vaccines. SN - 0033-2100 UR - https://www.unboundmedicine.com/medline/citation/25862449/Thiomersal_containing_vaccines___a_review_of_the_current_state_of_knowledge_ L2 - http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=1883 DB - PRIME DP - Unbound Medicine ER -